受强制性开放获取政策约束的文章 - Fable Zustovich了解详情
无法在其他位置公开访问的文章：1 篇
Role of dose exposure and inflammatory status in a single center, real-world analysis of sunitinib in patients with metastatic renal cell carcinoma
M Maruzzo, U Basso, A Diminutto, A Roma, F Zustovich, A Brunello, ...
Future Oncology 12 (7), 909-919, 2016
强制性开放获取政策： Government of Italy
可在其他位置公开访问的文章：7 篇
A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’study
F Loupakis, R Intini, C Cremolini, A Orlandi, A Sartore-Bianchi, ...
European Journal of Cancer 118, 121-130, 2019
强制性开放获取政策： Government of Italy
Neoplastic meningitis from solid tumors: new diagnostic and therapeutic approaches
G Lombardi, F Zustovich, P Farina, A Della Puppa, R Manara, D Cecchin, ...
The oncologist 16 (8), 1175-1188, 2011
强制性开放获取政策： US National Institutes of Health
Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours
C Celsa, G Cabibbo, CAM Fulgenzi, B Scheiner, A D’Alessio, GF Manfredi, ...
Journal of hepatology 80 (3), 431-442, 2024
强制性开放获取政策： Cancer Research UK, National Institute for Health Research, UK, Wellcome Trust
Real-world treatment with nivolumab or cabozantinib for metastatic renal cell carcinoma (mRCC) in the Veneto region of Italy: results of AMOUR study
M Maruzzo, F Pierantoni, A Bortolami, D Palleschi, A Zivi, M Nicodemo, ...
Targeted Oncology 17 (4), 467-474, 2022
强制性开放获取政策： Government of Italy
Association of tumor-infiltrating lymphocytes with recurrence score in hormone receptor-positive/HER2-negative breast cancer: Analysis of four prospective studies
F Miglietta, MV Dieci, T Giarratano, V Torri, M Giuliano, F Zustovich, ...
European Journal of Cancer 195, 113399, 2023
强制性开放获取政策： AIRC Foundation for Cancer Research in Italy
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric …
FS Di Lisa, E Krasniqi, L Pizzuti, M Barba, K Cannita, U De Giorgi, ...
Frontiers in Oncology 13, 1152123, 2023
强制性开放获取政策： Government of Italy
242MO Association of tumor-infiltrating lymphocytes (TILs) with recurrence score (RS) in patients with hormone receptor-positive (HR+)/HER2-negative (HER2-) early breast cancer …
F Miglietta, MV Dieci, T Giarratano, V Torri, M Giuliano, F Zustovich, ...
Annals of Oncology 34, S280, 2023
强制性开放获取政策： AIRC Foundation for Cancer Research in Italy
出版信息和资助信息由计算机程序自动确定